Outcome of Board Meeting and Un-Audited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2025.
MCX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.7 pts more than Nifty Midcap 150 and 6.2 pts more than its Capital Markets peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
MCX reported a very strong Q3 FY26 with consolidated income from operations more than doubling to ₹665.62 cr from ₹301.38 cr a year ago (over 120% YoY growth). Consolidated total income for the quarter stood at ₹697.11 cr versus ₹324.36 cr in Q3 FY25. Consolidated net profit after tax jumped to ₹401.12 cr from ₹160.04 cr (around 150% YoY growth), while 9M FY26 PAT came in at ₹801.78 cr versus ₹424.58 cr earlier. On a standalone basis, Q3 PAT was ₹307.10 cr (vs ₹122.20 cr) and 9M FY26 PAT was ₹620.41 cr (vs ₹313.11 cr). The Board also noted a 1:5 share subdivision (face value cut from ₹10 to ₹2, record date January 2, 2026) and made a ₹1.50 cr provision toward a SEBI-mandated financial disincentive following a brief business disruption on October 28-29, 2025.
Sharp doubling of both revenue and profits signals strong trading volumes and operating leverage on the exchange, which is positive for the stock and could support investor confidence. Minor watch points include the SEBI penalty provision and a change in statutory auditor (predecessor firm handled prior period reviews).